Top Banner
57 y.o former IVDU with known chronic 57 y.o former IVDU with known chronic hepatitis C cirrhosis hepatitis C cirrhosis found to found to have a mass in the liver have a mass in the liver
27
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Syspath 10   Lecture4 Liver Tumors

57 y.o former IVDU with known chronic hepatitis C cirrhosis 57 y.o former IVDU with known chronic hepatitis C cirrhosis found to have a mass in the liverfound to have a mass in the liver

Page 2: Syspath 10   Lecture4 Liver Tumors
Page 3: Syspath 10   Lecture4 Liver Tumors

Etiology of HCCEtiology of HCC• Common causes: Common causes: HBVHBV

HCVHCV Aflatoxin BAflatoxin B AlcoholAlcohol

• Rare causes: Rare causes: Contraceptive & Anabolic SteroidsContraceptive & Anabolic Steroids

Metabolic diseasesMetabolic diseases Storage diseasesStorage diseases Vinyl ChlorideVinyl Chloride Older ageOlder age

Page 4: Syspath 10   Lecture4 Liver Tumors

Some Facts about HCCSome Facts about HCC

• One of the most common cancers in the worldOne of the most common cancers in the world• Represents 80% of primary malignant liver Represents 80% of primary malignant liver

tumorstumors• 80% associated with HBV and / or HCV80% associated with HBV and / or HCV• Relative risk in HBsAg + about 200Relative risk in HBsAg + about 200• Cirrhosis present in 90%Cirrhosis present in 90%• Male predominance (4 to 8:1)Male predominance (4 to 8:1)• Incidence increase with ageIncidence increase with age

Page 5: Syspath 10   Lecture4 Liver Tumors

Rising Incidence of HCCA Byproduct of the Hepatitis C Epidemic

• Incidence of HCC- 1976-1980: 1.4/100,000

- 1991-1995: 2.4/100,000

• Mortality: 41%• Significant shift to younger (40-60) age group

• Approx. 3.9 million in U.S. infected with Hepatitis C- Infected in 1960’s and 1970’s

- After 20 yr, HCC will develop in 1.9-6.7%

El-Serag, NEJM 1999

Page 6: Syspath 10   Lecture4 Liver Tumors
Page 7: Syspath 10   Lecture4 Liver Tumors

Hepatocellular CarcinomaHepatocellular Carcinoma

Page 8: Syspath 10   Lecture4 Liver Tumors
Page 9: Syspath 10   Lecture4 Liver Tumors
Page 10: Syspath 10   Lecture4 Liver Tumors
Page 11: Syspath 10   Lecture4 Liver Tumors
Page 12: Syspath 10   Lecture4 Liver Tumors
Page 13: Syspath 10   Lecture4 Liver Tumors

Non-cirrhotic liver with HCC

Page 14: Syspath 10   Lecture4 Liver Tumors

Intrahepatic cholangiocarcinomaIntrahepatic cholangiocarcinoma

Page 15: Syspath 10   Lecture4 Liver Tumors

Intrahepatic Bile Duct CarcinomaIntrahepatic Bile Duct Carcinoma

• Resembles carcinoma of extrahepatic biliary tree

• Less frequent than HCC

• F:M ratio 1:1 (F more ?)

• No relation to cirrhosis

• Rarely invades portal vein

• Hypovascular

• Associated conditions:

primary sclerosing cholangitis, liver flukes, hepatolithiasis, fibrocystic liver disease, chronic hepatitis C, Thorotrast.

Page 16: Syspath 10   Lecture4 Liver Tumors
Page 17: Syspath 10   Lecture4 Liver Tumors
Page 18: Syspath 10   Lecture4 Liver Tumors

HCC vs CholangiocarcinomaHCC vs Cholangiocarcinoma

Cirrhosis Yes No

Underlyingdisease

Cirrhosis,HBV,HCV, ALD,others

PSC, C. sinensis,cystic disease,hepatolithiasis,Thorotrast

Increasedserum level

AFP CEA, CA19.9

Histology Trabecular Glandular

Immunostain Heppar 1, AFP,poly CEA

CK7 +, CK20 -

Page 19: Syspath 10   Lecture4 Liver Tumors

Angiosarcoma

Page 20: Syspath 10   Lecture4 Liver Tumors

Benign Neoplasms

• Cavernous hemangiomas – most common

• Hepatic Adenomas

• Focal Nodular Hyperplasia

Page 21: Syspath 10   Lecture4 Liver Tumors
Page 22: Syspath 10   Lecture4 Liver Tumors
Page 23: Syspath 10   Lecture4 Liver Tumors
Page 24: Syspath 10   Lecture4 Liver Tumors
Page 25: Syspath 10   Lecture4 Liver Tumors
Page 26: Syspath 10   Lecture4 Liver Tumors

Metastatic Colon Ca

Page 27: Syspath 10   Lecture4 Liver Tumors

Focal Nodular Hyperplasia